Ifeanyichukwu Ifechidere: D-dimer – Why is This Test Being Ordered – and What is It Actually Telling You?
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals, shared a post on LinkedIn:
“D-dimer: Why is this test being ordered – and what is it actually telling you?
A D-dimer result is easy to look at.
Understanding why it was ordered is much more important.
D-dimer is a fragment produced when cross-linked fibrin is broken down by plasmin.
So when you detect D-dimer in the blood, you’re seeing evidence that fibrin formation and fibrinolysis have occurred somewhere in the body.
But here is where interpretation gets interesting:
A raised D-dimer does NOT automatically mean the patient has a DVT or PE.
D-dimer can increase in many situations, including:
- Venous thromboembolism
- Recent surgery or trauma
- Infection/inflammation
- Pregnancy
- Increasing age
- Malignancy
- Other conditions associated with activation of coagulation and fibrinolysis
So why order it?
The key is that D-dimer is primarily useful in the right clinical context and with an appropriate pre-test probability assessment.
For suspected DVT or PE, a clinician may use a D-dimer result as part of a diagnostic pathway.
And this creates an important laboratory lesson:
The test result doesn’t exist in isolation.
A negative D-dimer, when an appropriate assay and validated diagnostic pathway are used in a patient with sufficiently low clinical probability, can help exclude VTE.
A positive D-dimer, however, usually doesn’t tell you where the clot is or why the D-dimer is elevated. Further clinical assessment and, where indicated, imaging may be required.
There are also laboratory considerations that matter:
- What assay is being used?
- What are its units and reporting conventions?
- What cutoff applies?
- Is an age-adjusted threshold appropriate?
- Was the sample collected and handled correctly?
- Does the clinical context support using D-dimer as a rule-out test?
This is why simply remembering ‘high D-dimer doesn’t mean clot’ can lead to poor interpretation.
The better question is:
‘What clinical question was this D-dimer ordered to answer?’
Once you understand that, the result starts to make much more sense.
Follow me for more practical coagulation education – where we go beyond memorising results and learn how to understand the reasoning behind them.”

Other posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.
-
Nov 14, 2026, 15:30Patient Selection for Gene Therapy in Transfusion-Dependent β-Thalassemia – EHA
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter
-
Nov 14, 2026, 15:00Ram Mohan Jaiswal: International Collaboration in Transfusion Medicine Through the Trans Med Africa Consortium
-
Nov 14, 2026, 14:48Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa
-
Nov 14, 2026, 14:19Samuele Ferrari: Launching a New Era in Hematopoietic Genome Editing Research
-
Nov 14, 2026, 14:17Stefan Hofer: International Training in Postpartum Hemorrhage Management